ARDS, Human
117
12
14
48
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.4%
11 terminated out of 117 trials
81.4%
-5.2% vs benchmark
6%
7 trials in Phase 3/4
8%
4 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 48 completed trials
Clinical Trials (117)
Digital Early Warning System for Acute Lung Injury in Liver Surgery
Characterization of the microVAScular Dysfunction in Covid-19 ARDS
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome
Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning Pathway
Regional Citrate Anticoagulation for RRT During V-V ECMO
Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.
Feasabilty and Physiological Effects of a Ventilation Strategy Combining PEEP and Tidal Volume Titration According to Inspiratory and Expiratory Transpulmonary Pressures in ARDS Patients.
Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome
PET - PEEP by EIT for Acute Respiratory Distress Syndrome Trial
AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients
Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection
Treatment of ARDS With Instilled T3
Comparison of the Proteome in ICU Patients in Search for TRALI Biomarkers: A Case-control Study Using Both Retrospective and Prospective Samples
Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections
Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.
Screening Expiratory Flow Limitation by Flow-time Curve
Alveolar Macrophage Programming Following Endotoxin Exposure